시장보고서
상품코드
2143371

단핵구 활성화 검사 시장 : 제품 유형별, 용도별, 원료별, 최종사용자별, 국가별, 지역별 - 세계 산업 분석, 시장 규모, 시장 점유율 및 예측(2026-2033년)

Monocyte Activation Test Market, By Product Type, By Application, By Source, By End User, By Country, and By Region -Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033

발행일: | 리서치사: 구분자 AnalystView Market Insights | 페이지 정보: 영문 265 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




가격
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.
US $ 3,250 금액 안내 화살표 ₩ 4,396,000
PDF (5 User License) help
PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 4,560 금액 안내 화살표 ₩ 6,169,000
PDF & Excel (Enterprise User License) help
PDF & Excel 보고서를 동일 기업 내 모든 사용자가 사용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 5,650 금액 안내 화살표 ₩ 7,643,000
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

단핵구 활성화 시험 시장 규모는 2025년에 6억 2,080만 달러로 평가되며, 2026년부터 2033년까지 CAGR 15.8%로 확대될 것으로 전망됩니다.

단핵구 활성화 시험(MAT라고도 함)은 내독소 시험과 보다 광범위한 안전성 검사 사이에 위치하는 실험실 내 발열원 시험입니다. 이 시험에서는 전혈, 혈액 단핵구 또는 특수한 단핵구계 세포를 사용하여 내독소나 기타 발열원이 존재할 경우 염증이 발생하는지 여부를 판정합니다. 이 시험은 체내에 투여되는 의약품, 바이오의약품, 백신 및 의료기기가 시장에 유통되기 전에 발열원이 검출되지 않음을 입증하는 데 중요합니다. 본 시험의 제공 형태는 세포 원료의 적격성, 측정 대상 사이토카인의 종류, 제품의 검증 방법, 그리고 표준 키트 및 시약의 입수 가능성에 따라 달라집니다. 2025년 7월 1일, 큰 변화가 있었습니다. 유럽 약전(European Pharmacopoeia)이 발열성 관련 규정을 개정하여, 57개 개정 조항에서 기존의 토끼 시험을 삭제했습니다. 이 변경으로 인해 MAT는 단순한 시험법의 틀을 넘어, 오늘날 발열성 물질 관리 전략의 핵심을 이루게 되었습니다.

단핵구 활성화 시험 시장 - 시장 역학

동물을 이용한 발열성 시험의 규제상 대안

이 시장의 가장 강력한 촉진요인은 토끼를 이용한 발열성 시험에서 과학적으로 입증된 체외(in vitro) 방식으로의 전환입니다. 2025년 7월 1일부터 유럽 약전은 발열성 관련 프레임워크를 개정하여, 의약품 개발자에게 자사 제품의 위험 프로필에 부합하는 체외(in vitro) 전략을 선택할 것을 의무화했습니다. 다양한 선택지 중에서도 MAT(단핵구 활성화 시험)가 명확한 접근 방식 중 하나로 자리매김했습니다. 이 변경에 따라 초점은 발열원 분석법 구매에서, 일상적인 품질 관리에 사용할 수 있는 검증 완료 및 이전 가능한 시험 워크플로우 구축으로 옮겨가고 있습니다. 그 결과, 각 공급업체는 세포 제공, 보다 간편한 프로토콜, 자동화 도구, 그리고 결과 판독에 있어 새로운 기법을 제안함으로써 타사와의 차별화를 꾀하고 있습니다. 예를 들어, 미네르바 바이오랩(Minerva BioLab)의 2025년형 NAT-MAT 시스템은 사이토카인 측정에 기존의 ELISA 대신 PCR을 채택하고 있습니다. 이는 규제가 공정뿐만 아니라 제품 설계 측면에서도 변화를 촉진하고 있음을 보여줍니다. 그 결과, 단순한 분석 구성요소에 그치지 않고 표준화되고 운영 효율이 높은 MAT 플랫폼으로의 전환이 진행되고 있습니다.

단핵구 활성화 검사 시장 - 시장 세분화 분석:

세계 단핵구 활성화 검사 시장은 제품 유형, 용도, 검체 출처, 최종사용자 및 지역을 기준으로 세분화되어 있습니다.

제품 유형별로 살펴보면, 그 구성은 실험실이 유연성과 워크플로우의 표준화를 어떻게 양립시키고 있는지를 보여줍니다. 숙련된 분석 팀이 기존 실험실 프로토콜에 따라 세포 준비, 자극, 사이토카인 검출 및 대조군을 맞춤화하는 것을 선호하는 환경에서는 시약이 여전히 중요한 역할을 하고 있습니다. 대조적으로, MAT 키트는 이러한 구성요소를 체계화된 검사 시스템으로 통합하여, 이를 통해 방법 전환을 용이하게 하고 일상적인 릴리스 테스트를 지원합니다. 이러한 차이는 실험실이 개발 실험 단계에서 검증된 품질 관리 프로세스로 전환함에 따라 더욱 중요해집니다. 예를 들어, 머크의 ‘PyroMAT’는 MAT 시약과 IL-6 ELISA 기반 검출법을 결합한 것으로, 개별 소모품에 의존하기보다는 완전히 통합된 검사 방식으로 나아가는 추세를 보여줍니다. 그 결과, 제품 간의 차이는 재현성, 세포 적합성, 문서화 및 사용 편의성에 기반을 두게 되었습니다. 키트는 워크플로우 솔루션으로 자리 잡아가고 있는 반면, 시약은 실험실 수준에서 보다 세밀한 제어를 계속해서 제공하고 있습니다.

용도별로 보면 각 사용 사례의 요구 사항이 MAT 시스템 구축 및 검증 방법을 결정합니다. 제품의 피로젠 프로파일은 개발 단계에 있는지, 아니면 출하 단계에 있는지에 따라 달라집니다. 의료기기 시험에서는 추출 기술과 그 방법이 다양한 기기 재료에 대해 어느 정도 효과적인지에 초점이 맞춰집니다. 의약품 개발에서는 시스템이 분석 개발 단계와 출하 단계 모두에서 제제에 의한 간섭을 관리해야 합니다. 백신 개발에는 또 다른 과제가 있습니다. 일부 백신 성분은 본래 활성을 가지고 있기 때문에 엔도톡신 단독 시험만으로는 불충분하기 때문입니다. 2025년 머크(Merck)사가 실시한 연구에서는 외막 단백질 백신을 대상으로, 기준 로트와 비교하여 상대 발열성이 25%에서 300% 범위에 이르는 MAT를 시험하여, 용도 특이적 검증(validation)이 분석법 설계에 어떻게 영향을 미치는지를 보여주었습니다. 이는 각 제품의 생물학적 특성에 맞춰 검증 전략을 조정할 수 있는 플랫폼이, 용도의 구조상 선호된다는 것을 의미합니다.

단핵구 활성화 시험(MAT) 시장 - 지역별 인사이트

유럽은 약전 체계가 단순한 대체 발열원 시험 허용에 그치지 않는 단계로 발전함에 따라 MAT의 기준점이 되고 있습니다. 개정된 유럽 약전 프레임워크는 2025년 7월 1일에 발효되었으며, 토끼 유래 발열원에 관한 구체적인 장은 그 후 2026년 1월에 삭제될 예정이었습니다. 이 프레임워크에서는 MAT를 대체 방법으로 의무화하지는 않습니다. 대신 개발자는 위험 평가를 통해 적절한 체외(in vitro) 방법을 선택해야 하며, MAT는 주요 대체 방법 중 하나로 언급되고 있습니다. 이러한 차이는 상업적으로 중요합니다. 왜냐하면 검사 기관은 단순히 어세이 키트를 구매하는 것이 아니라, 제품 검증과 확고한 기술 문서로 뒷받침되는 방법을 요구하기 때문입니다. 따라서 유럽은 검증의 중심지 역할을 수행하고 있으며, 공급업체들에게 세포주, 측정값 및 문서를 유럽 약전(Ph. Eur.) 2.6.30의 요건에 부합하도록 할 것을 촉구하고 있습니다.

아시아태평양은 연구 개발, 대체 시험법 개발 및 지역 고유의 기술 플랫폼을 통해 그 역할을 수행해 나가고 있습니다. 한국의 연구진은 2025년 3월, 서울대학교, 대구경북의료혁신재단 및 국립식품의약품안전평가원의 협력을 얻어, 규제 당국의 승인, 검증, 의약품 시험 및 의료기기 적용을 포괄하는 MAT에 관한 구체적인 리뷰를 발표했습니다. 일본 또한 표준화된 단핵구계 세포를 둘러싼 기술 개발을 추진하고 있습니다. NEDO의 2025년 프로그램에서는 교토에 본사를 둔 MiCAN Technologies사가 불사화된 aMylc 세포를 이용한 MylcMAT 제품 개발을 중점적인 딥테크 연구 주제로 삼고 있습니다. 이러한 연구 개발과 지역 고유의 세포 플랫폼 개발의 융합을 통해, 해당 지역은 기증자 유래 시스템에 대한 의존도를 낮추고, 분석의 일관성을 높이는 데 있어 확고한 입지를 다지고 있습니다.

목차

제1장 단핵구 활성화 검사 시장 개요

제2장 주요 요약

제3장 단핵구 활성화 검사 주요 시장 동향

제4장 단핵구 활성화 검사 산업 분석

제5장 단핵구 활성화 검사 시장 : 높아지는 지정학적 긴장의 영향

제6장 단핵구 활성화 검사 시장 구도

제7장 단핵구 활성화 검사 시장 : 제품 유형별

제8장 단핵구 활성화 검사 시장 : 용도별

제9장 단핵구 활성화 검사 시장 : 원료별

제10장 단핵구 활성화 검사 시장 : 최종사용자별

제11장 단핵구 활성화 검사 시장 : 지역별

제12장 주요 벤더 분석 : 단핵구 활성화 검사 산업

제13장 AnalystView의 전방위 전망

KSM 26.10.14

Monocyte Activation Test Market size was valued at US$ 620.8 Million in 2025, expanding at a CAGR of 15.8% from 2026 to 2033.

Monocyte Activation Test, also known as MAT, are laboratory pyrogen tests that exist between endotoxin tests and broader safety checks. They use whole blood, blood mononuclear cells, or special monocytic cells to determine if inflammation occurs when endotoxins or other pyrogens are present. This test is important for medicines injected into the body, biopharmaceuticals, vaccines, and medical devices that must show no pyrogens before they are released. The way the test is sold depends on how the cell source is qualified, which cytokines are measured, how the product is validated, and whether standard kits and reagents are available. A major change occurred on July 1, 2025: the European Pharmacopoeia updated its rules regarding pyrogenicity and removed the old rabbit test from 57 updated texts. This shift made MAT less of a method and more of a central part of today's pyrogen control strategies.

Monocyte Activation Test Market- Market Dynamics

Regulatory Replacement of Animal-Based Pyrogen Testing

The strongest market-specific catalyst is the shift away from the rabbit pyrogen test toward scientifically supported in vitro methods. Starting July 1, 2025, the European Pharmacopoeia updated its pyrogenicity framework, requiring medicine developers to choose an in vitro strategy that matches their product's risk profile. Among the options, MAT was clearly identified as one approach. This change moves the focus from buying a pyrogen assay to building a validated and transferable testing workflow that can be used in routine quality control. As a result, suppliers are distinguishing themselves by offering cells, easier protocols, automation tools, and new ways to read results. Take Minerva Biolabs' 2025 NAT-MAT system, for example-it uses PCR instead of traditional ELISA for cytokine measurement. This demonstrates how regulation is driving changes not just in process but also in product design. The outcome is a growing move toward standardized and operationally efficient MAT platforms, not just simple assay parts.

Monocyte Activation Test Market- Segmentation Analysis:

The Global Monocyte Activation Test Market is segmented on the basis of Product Type, Application, Source, End User, and Region.

By product type, the product split shows how laboratories balance flexibility with workflow standardization. Reagents remain important in settings where skilled analytical teams prefer to customize cell preparation, stimulation, cytokine detection, and controls based on their existing lab protocols. In contrast, MAT kits bundle these components into a structured testing system that makes method transfer easier and supports routine release testing. This difference matters most as labs shift from development experiments to verified quality control processes. Merck's PyroMAT, for example, combines MAT reagents with IL-6 ELISA-based detection methods, showing a trend toward fully integrated testing instead of relying on separate consumables. As a result, product differences are increasingly based on reproducibility, cell qualification, documentation, and ease of use. Kits are becoming workflow solutions while reagents continue to offer more control at the lab level.

By application, the needs of each use case drive how MAT systems are set up and validated. The pyrogenic profile of a product varies depending on whether it is in development or release. In medical device testing, the focus is on extraction techniques and how well the method works with different device materials. In drug development, the system must manage formulation interference during both analytical development and release steps. Vaccine development presents another challenge because some vaccine ingredients naturally exhibit activity, meaning endotoxin-only testing isn't enough. A 2025 Merck study tested an MAT for an outer-membrane-protein vaccine across relative pyrogenicity levels from 25% to 300% compared to a reference lot, showing how application-specific validation affects assay design. This means the application structure favors platforms that can adjust validation strategies to match the biological traits of each product.

Monocyte Activation Test Market- Geographical Insights

Europe has become the reference point for MAT because its pharmacopoeial framework has moved beyond merely allowing alternative pyrogen testing. The European Pharmacopoeia's updated framework became effective on July 1, 2025, while the specific rabbit pyrogen chapter was later planned for removal in January 2026. The framework does not require MAT as the replacement; developers must instead use risk assessments to choose a suitable in vitro method, with MAT listed as one of the main alternatives. This difference is important commercially because laboratories need methods that are backed by product verification and strong technical documentation instead of just purchasing an assay. Europe, therefore, acts as a validation center, pushing suppliers to align cell systems, readouts, and documentation with Ph. Eur. 2.6.30 requirements.

Asia-Pacific is taking on a role through research, development of alternative testing, and local technology platforms. Korean researchers released a specific MAT review in March 2025 covering regulatory approval, validation, pharmaceutical testing, and medical-device applications, with input from the University of Seoul, Daegu Gyeongbuk Medical Innovation Foundation, and the National Institute of Food and Drug Safety Evaluation. Japan is also creating technology around standardized monocytic cells: NEDO's 2025 program highlights Kyoto-based MiCAN Technologies' development of MylcMAT products using immortalized aMylc cells as a supported deep-tech research theme. This mix of research and local cell-platform development gives the region a strong position in reducing reliance on donor-derived systems and making assays more consistent.

Monocyte Activation Test Market- Competitive Landscape:

Competition is moving away from pyrogen detection toward better control of biological variability, higher assay sensitivity, shorter workflow times, and greater scalability. Suppliers differentiate themselves through cell sources, standardized monocytic lines, cytokine readouts, and integrated validation support. For example, CTL - MAT states that its manufacturing network can supply up to 2,000 vials of pooled cryopreserved PBMCs per batch, which solves one of the limitations that arise from maintaining a consistent cell supply across testing programs. Other suppliers are pursuing technology architectures: Minerva uses digital PCR and standardized HL - 60 - derived cells, while MiCAN is developing immortalized monocyte systems that aim to improve reproducibility and supply stability. The competitive boundary is therefore shifting toward scalable testing platforms rather than conventional reagent supply alone.

Recent Developments:

In April 2025, Minerva Biolabs launched the NAT-MAT(R) System. This system combines monocyte activation testing with PCR for pyrogen detection. The company stated that the workflow uses 4 hours of cell stimulation instead of the overnight stimulation used in conventional ELISA-based MAT workflows.

In September 2025, Merck researchers published a reporter-cell MAT designed for the release testing of vaccines that contain inherently pyrogenic components. The validation study was carried out in 14 experiments. The study found repeatability and intermediate precision of 6.9 percent RSD.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL MONOCYTE ACTIVATION TEST MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Merck KGaA
  • Lonza Group
  • Thermo Fisher Scientific
  • Charles River Laboratories
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories
  • Sanquin Diagnostiek B.V.
  • Eurofins Scientific
  • Microcoat Biotechnologie GmbH
  • SOLVIAS AG
  • Seikagaku Corporation
  • Hyglos GmbH
  • Wako Chemicals USA
  • MAT BioTech B.V.
  • Cellular Technology Limited (CTL)
  • Others

GLOBALMONOCYTE ACTIVATION TEST MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2020 - 2033

  • Reagents
  • MAT Kits

GLOBAL MONOCYTE ACTIVATION TEST MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033

  • Medical Device Testing
  • Drug Development
  • Vaccine Development
  • Others

GLOBAL MONOCYTE ACTIVATION TEST MARKET, BY SOURCE- MARKET ANALYSIS, 2020 - 2033

  • Cell Line Based
  • PBMC Based

GLOBAL MONOCYTE ACTIVATION TEST MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033

  • Biotechnology
  • Pharmaceutical
  • Medical Device
  • Others

GLOBAL MONOCYTE ACTIVATION TEST MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Denmark
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Taiwan
  • Vietnam
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Iran
  • Qatar
  • Rest of MEA

Table of Contents

1. Monocyte Activation Test Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
  • 2.2. Competitive Insights

3. Monocyte Activation Test Key Market Trends

  • 3.1. Monocyte Activation Test Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Monocyte Activation Test Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Monocyte Activation Test Market Opportunities
  • 3.4. Monocyte Activation Test Market Future Trends

4. Monocyte Activation Test Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Monocyte Activation Test Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Monocyte Activation Test Market Landscape

  • 6.1. Monocyte Activation Test Market Share Analysis, 2025
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Monocyte Activation Test Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2025 & 2033 (%)
    • 7.1.2. Reagents
    • 7.1.3. MAT Kits

8. Monocyte Activation Test Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
    • 8.1.2. Medical Device Testing
    • 8.1.3. Drug Development
    • 8.1.4. Vaccine Development
    • 8.1.5. Others

9. Monocyte Activation Test Market - By Source

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Source, 2025 & 2033 (%)
    • 9.1.2. Cell Line Based
    • 9.1.3. PBMC Based

10. Monocyte Activation Test Market - By End User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End User, 2025 & 2033 (%)
    • 10.1.2. Biotechnology
    • 10.1.3. Pharmaceutical
    • 10.1.4. Medical Device
    • 10.1.5. Others

11. Monocyte Activation Test Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Monocyte Activation Test Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Source, 2020 - 2033 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Source, 2020 - 2033 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Source, 2020 - 2033 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Monocyte Activation Test Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Source, 2020 - 2033 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Source, 2020 - 2033 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.9.3. UK Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.3.9.4. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.9.5. UK Market Size and Forecast, By Source, 2020 - 2033 (US$ Million)
      • 11.3.9.6. UK Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.10.3. France Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.3.10.4. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.10.5. France Market Size and Forecast, By Source, 2020 - 2033 (US$ Million)
      • 11.3.10.6. France Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.11.3. Italy Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.3.11.4. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.11.5. Italy Market Size and Forecast, By Source, 2020 - 2033 (US$ Million)
      • 11.3.11.6. Italy Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.12.3. Spain Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.3.12.4. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.12.5. Spain Market Size and Forecast, By Source, 2020 - 2033 (US$ Million)
      • 11.3.12.6. Spain Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By Source, 2020 - 2033 (US$ Million)
      • 11.3.13.6. The Netherlands Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Source, 2020 - 2033 (US$ Million)
      • 11.3.14.6. Sweden Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.15.3. Russia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.3.15.4. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.15.5. Russia Market Size and Forecast, By Source, 2020 - 2033 (US$ Million)
      • 11.3.15.6. Russia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By Source, 2020 - 2033 (US$ Million)
      • 11.3.16.6. Poland Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.3.17. Denmark
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.17.3. Denmark Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.3.17.4. Denmark Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.17.5. Denmark Market Size and Forecast, By Source, 2020 - 2033 (US$ Million)
      • 11.3.17.6. Denmark Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.3.18. Rest of Europe
      • 11.3.18.1. Overview
      • 11.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.18.3. Rest of the Europe Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.3.18.4. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.18.5. Rest of the Europe Market Size and Forecast, By Source, 2020 - 2033 (US$ Million)
      • 11.3.18.6. Rest of the Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Monocyte Activation Test Key Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.4.4. APAC Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.4.5. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.4.6. APAC Market Size and Forecast, By Source, 2020 - 2033 (US$ Million)
    • 11.4.7. APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.8.3. China Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.4.8.4. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.8.5. China Market Size and Forecast, By Source, 2020 - 2033 (US$ Million)
      • 11.4.8.6. China Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.9.3. India Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.4.9.4. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.9.5. India Market Size and Forecast, By Source, 2020 - 2033 (US$ Million)
      • 11.4.9.6. India Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Source, 2020 - 2033 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Source, 2020 - 2033 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Source, 2020 - 2033 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.13.5. Indonesia Market Size and Forecast, By Source, 2020 - 2033 (US$ Million)
      • 11.4.13.6. Indonesia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.14.3. Thailand Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.4.14.4. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.14.5. Thailand Market Size and Forecast, By Source, 2020 - 2033 (US$ Million)
      • 11.4.14.6. Thailand Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Source, 2020 - 2033 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.4.16. Taiwan
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.16.3. Taiwan Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.4.16.4. Taiwan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.16.5. Taiwan Market Size and Forecast, By Source, 2020 - 2033 (US$ Million)
      • 11.4.16.6. Taiwan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.4.17. Vietnam
      • 11.4.17.1. Overview
      • 11.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.17.3. Vietnam Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.4.17.4. Vietnam Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.17.5. Vietnam Market Size and Forecast, By Source, 2020 - 2033 (US$ Million)
      • 11.4.17.6. Vietnam Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.4.18. Rest of APAC
      • 11.4.18.1. Overview
      • 11.4.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.18.3. Rest of APAC Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.4.18.4. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.18.5. Rest of APAC Market Size and Forecast, By Source, 2020 - 2033 (US$ Million)
      • 11.4.18.6. Rest of APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. Monocyte Activation Test Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.5.4. LATAM Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.5.5. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.5.6. LATAM Market Size and Forecast, By Source, 2020 - 2033 (US$ Million)
    • 11.5.7. LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Source, 2020 - 2033 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Source, 2020 - 2033 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Source, 2020 - 2033 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Source, 2020 - 2033 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Source, 2020 - 2033 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. Monocyte Activation Test Key Manufacturers in Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.6.4. MEA Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.6.5. MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.6.6. MEA Market Size and Forecast, By Source, 2020 - 2033 (US$ Million)
    • 11.6.7. MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Source, 2020 - 2033 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Source, 2020 - 2033 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Source, 2020 - 2033 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Source, 2020 - 2033 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Source, 2020 - 2033 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Source, 2020 - 2033 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.6.14. Iran
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.14.3. Iran Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.6.14.4. Iran Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.14.5. Iran Market Size and Forecast, By Source, 2020 - 2033 (US$ Million)
      • 11.6.14.6. Iran Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.6.15. Qatar
      • 11.6.15.1. Overview
      • 11.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.15.3. Qatar Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.6.15.4. Qatar Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.15.5. Qatar Market Size and Forecast, By Source, 2020 - 2033 (US$ Million)
      • 11.6.15.6. Qatar Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.6.16. Rest of MEA
      • 11.6.16.1. Overview
      • 11.6.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.16.3. Rest of MEA Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.6.16.4. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.16.5. Rest of MEA Market Size and Forecast, By Source, 2020 - 2033 (US$ Million)
      • 11.6.16.6. Rest of MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)

12. Key Vendor Analysis- Monocyte Activation Test Industry

  • 12.1. Competitive Benchmarking
    • 12.1.1. Competitive Dashboard
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. Merck KGaA
    • 12.2.2. Lonza Group
    • 12.2.3. Thermo Fisher Scientific
    • 12.2.4. Charles River Laboratories
    • 12.2.5. Becton, Dickinson and Company
    • 12.2.6. Bio-Rad Laboratories
    • 12.2.7. Sanquin Diagnostiek B.V.
    • 12.2.8. Eurofins Scientific
    • 12.2.9. Microcoat Biotechnologie GmbH
    • 12.2.10. SOLVIAS AG
    • 12.2.11. Seikagaku Corporation
    • 12.2.12. Hyglos GmbH
    • 12.2.13. Wako Chemicals USA
    • 12.2.14. MAT BioTech B.V.
    • 12.2.15. Cellular Technology Limited (CTL)
    • 12.2.16. Others

13. 360 Degree AnalystView

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제
문의
원하시는 정보를
찾아 드릴까요?
문의주시면 필요한 정보를
신속하게 찾아드릴게요.
02-2025-2992
email
문의하기